Welcome to our dedicated page for ETRACS Whitney US Critical Techs ETN SEC filings (Ticker: WUCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for WUCT aggregates regulatory documents tied to ETRACS Whitney US Critical Technologies ETNs issued by UBS AG, a foreign private issuer. The core filings here are Forms 6-K, which provide interim financial and legal updates that are incorporated by reference into UBS AG’s Form F-3 registration statement for securities offerings.
In these Form 6-K reports, UBS AG discloses consolidated capitalization in US dollars under IFRS Accounting Standards, detailing short-term and long-term debt issued by UBS AG and its subsidiaries, funding from UBS Group AG, equity attributable to shareholders and non-controlling interests, and total capitalization. Such information helps investors understand the broader balance sheet context of the issuer behind the WUCT-linked ETNs.
The filings also explain how specific 6-K reports are incorporated into UBS AG’s Form F-3 registration statement and any outstanding prospectuses or offering circulars that reference those 6-Ks. This structure means that updates filed on Form 6-K become part of the official documentation for securities, including the ETRACS Whitney US Critical Technologies ETNs associated with WUCT.
Another Form 6-K on this page consists of the opinion of Homburger AG, acting as special Swiss counsel to UBS AG, which is filed as an exhibit to the Form F-3 registration statement and replaces a prior opinion. This highlights the role of legal opinions in UBS AG’s securities registration process.
On Stock Titan, users can access these filings in one place, with AI-powered tools available to summarize key sections, highlight important capitalization and legal disclosures, and help interpret how each new Form 6-K or related document fits into UBS AG’s overall reporting framework for the WUCT-linked ETNs.
UBS AG London Branch is offering Contingent Income Auto-Callable Securities linked to the common stock of Wells Fargo & Company (WFC). The notes are being issued under a 424(b)(2) filing and settle on, or about, 9 July 2025 with a scheduled maturity of 7 July 2028 (three-year term).
Key structural features
- Stated principal amount: $1,000 per security.
- Contingent coupon: $26.375 per quarter (≈10.55% p.a.) paid only if the closing price of WFC on the relevant determination date is ≥ 70% of the initial price (the “downside threshold”).
- Auto-call: If WFC closes ≥ 100% of the initial price (the “call threshold”) on any quarterly determination date before the final one, the notes are redeemed early at par plus that period’s coupon.
- Principal repayment at maturity: • If final price ≥ 70% of initial price: par + final coupon. • If final price < 70%: investors receive a cash value reflecting the full downside in WFC (no shares delivered), resulting in a loss of 30% to 100% of principal.
- Credit & liquidity: Unsubordinated, unsecured obligations of UBS AG. Not listed on any exchange; secondary market trading depends on dealer willingness.
Economics & fees
- Issue price: 100% of par.
- Total selling concession: 2.25% (1.75% sales commission + 0.50% structuring fee) retained by Morgan Stanley Wealth Management.
- Estimated initial value: $939.50 – $969.50 (≈ 94-97% of issue price), indicating a 3-6% built-in negative yield versus a hypothetical risk-free bond.
Risk considerations highlighted by UBS
- Investors forfeit coupons during any quarter in which WFC closes < 70% of the initial price.
- No principal protection; losses accelerate one-for-one below the 70% threshold.
- All payments subject to UBS AG credit risk.
- No listing; limited or no secondary liquidity could force investors to hold to call or maturity.
- Potential conflicts of interest because UBS and affiliated dealers act as calculation agent, issuer, and secondary-market counterparty.
The offering targets income-oriented investors prepared to accept single-stock exposure to WFC, substantial downside risk, and issuer credit risk in exchange for an above-market conditional coupon and an auto-call feature.
UBS AG filed a Rule 424(b)(2) pricing supplement dated 26 June 2025 for $309,000 of Trigger Autocallable Contingent Yield Notes linked to the common stock of NVIDIA Corporation. The Notes are unsubordinated, unsecured debt of UBS and will not be listed on any exchange.
Key commercial terms include: (i) Issue price of $10.00 per Note with minimum purchase of 100 Notes; (ii) Contingent coupon of 9.43% per annum, payable quarterly only when NVIDIA’s closing price on the observation date is at or above the 50% coupon barrier ($77.51); (iii) an automatic call feature that redeems the Notes at par plus the coupon if the underlying closes at or above the initial level ($155.02) on any quarterly observation date before maturity; (iv) downside threshold also set at 50% of the initial level. If the Notes are not automatically called and NVIDIA ends below this threshold on the final valuation date (28 June 2027), investors participate one-for-one in the decline and could lose their entire principal; (v) final maturity 30 June 2027.
The filing highlights multiple risk factors, notably credit exposure to UBS, potential loss of principal, absence of market listing, liquidity constraints and an estimated initial value of $9.79 per Note, below the public offering price. Underwriting discount is $0.15 per Note, leaving net proceeds to UBS of $9.85 per Note.
Investors are advised to review the accompanying prospectus (dated 6 Feb 2025) and product supplement for detailed descriptions of market disruption adjustments, tax considerations, and key risks. UBS emphasises that higher coupon rates correlate with higher downside risk and that the contingent principal protection applies only at maturity.